MAPT and early-onset autosomal dominant Alzheimer disease: created an early Alzheimer’s disease (AD) rat model by injecting okadaic acid (OA) into the rats’ hippocampus, which activated GSK-3, increased higher oxidative stress, generated tau hyperphosphorylation, and increased βA neurotoxicity.